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ABSTRACT
High  transmission  rate  and  drug  resistance  have  been  implicated  in  the   spread   and
re-emergence of malaria in areas where the disease had been eradicated. The objective of this study
was to determine the prevalence of falciparum malaria and pre-disposing factors to malaria among
patients presenting with fever in selected State Hospitals in Ogun State, Southwestern Nigeria.
Four thousand and sixty six patients were recruited into this study. Scientific and Ethical clearance
was obtained for this study. Blood samples were collected for malaria screening from the subjects.
Structured questionnaires were administered to patients and parents of infants to determine the
factors that could lead to the development of drug resistance by the parasite in the study
population. Out of 4066 subjects screened during the study period, 61.1% were positive for
falciparum malaria. Highest prevalence of 70.8% was recorded in children 1-5 years, also the group
with highest parasitemia (1080). The study showed that 24.6% of the patient visited hospitals for
treatment, 12% use local healers while 25.0% bought antimalarial drugs without prescription.
Moreover, some subjects use more than one method in their management of malaria. Those who
combined antimalarial drugs with traditional medicine from local healers were 17.4%. Only 18%
of the sample population used insecticide treated mosquito nets, 42.3% used window and door nets,
while 13% did not employ any mosquito preventive method. Uncontrolled use of drugs and exposure
of parasites to the drugs should be monitored in areas where the parasite is still sensitive to the
drug.
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INTRODUCTION
Malaria has been a common disease and it continues to be one of the most widely spread health
hazards in tropical and subtropical regions. More than half of the world’s population lives in the
areas where they remain at risk of malarial infection. The vast majority of cases occur in children
under the age of five years and pregnant women (Greenwood et al., 2005; Olasehinde et al., 2010).
It is one of the major public health problems in Nigeria, contributing a quarter of the malaria
burden in Africa (WHO., 2010). This disease is the most important cause of human morbidity and
mortality with enormous medical, emotional and economic impact in the world (Foster and Phillips,
1998; Ogungbamigbe et al., 2005). Malaria occurs in nearly 100 countries worldwide. According to
the   World   Malaria   Report   2013,   there  were  more  than  200  million  malaria  cases  in  2012
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(WHO.,  2013).  An  estimated  627,000  people  died  from  malaria  in  2012,  90%  of  them  in
Sub-Saharan Africa. Nigeria, the Democratic Republic of Congo, Uganda, Ethiopia and Tanzania
account for 50% of the global deaths and 47% of all malaria cases (WHO., 2015). The vast majority
of cases occur in children under the age of five years and pregnant women (Olasehinde et al., 2010).
The number of new cases has declined by 25% globally and deaths from malaria have fallen by 42%
(WHO., 2015). However, current tools and treatments are insufficient to achieve elimination in
many countries and the cost of maintaining these interventions has reached several billion dollars
a year. The malaria parasite has developed resistance to currently available insecticides and drugs
and these resistant strains will spread. Infected individuals who are asymptomatic are the majority
of those infected and they remain an ongoing source of transmission. Despite increasing efforts to
control the disease, the burden of malaria has remained high in many African countries due to
persistent high level of transmission (Griffin et al., 2010). Antimalarial drug resistance has
emerged as one of the greatest challenges facing malaria control today. The emergence of
Plasmodium falciparum resistance to artemisinin derivatives (ART) in Cambodia threatens the
world’s malaria control and elimination efforts (Ariey et al., 2014). The risk of ART-resistant
parasites spreading from Western Cambodia to the Greater Mekong Sub-region and to Africa, as
it has happened previously with chloroquine and sulphadoxine/pyrimethamine-resistant parasites,
is extremely worrisome. There is no single factor that confers the greatest degree of influence on
the spread of drug resistance, but a number of plausible causes associated with an increase in the
spread of drug resistance have been acknowledged. These include aspects of economics, human
behaviors, pharmacokinetics and the biology of vectors and parasites. In this study, prevalence of
malaria was determined and the factors that could be responsible for development of drug
resistance in the parasite was investigated.
MATERIALS AND METHODS
Study  subjects:  Children  between  1-15  years,  pregnant  women  and  other  adults  less  than
70 years were included in this study. This is because majority of malaria cases occur in children
under the age of 12 years and pregnant women are also especially vulnerable. The blood samples
were collected and analyzed between April 2011 and June, 2013.
Study site: Ogun State, the study site was divided into 4 zones for sample collection. The 4 zones
are: Sango-Ota (Yewa), Abeokuta (Egba), Ijebu-Ode (Ijebu) and Sagamu (Remo) (Fig. 1).
Using the population size of each zone and the rate of prevalence of malaria in the state, the
sample size for each of the four zones was calculated with a 95% CI and precision level of 5% as
follows:
n = Z2 P(1-P)2/d2
Where:
n = Sample size
Z = 1.96 at 95%
P = Prevalence rate
d = Sampling error that can be tolerated (0.05)
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Fig. 1: Map of Ogun State, Southwestern Nigeria
State general hospitals located in the different zones were used as sample collection centers.
Both in and out patients who presented with uncomplicated malaria in the hospitals were recruited
on the research work. Four thousand and sixty six patients were recruited into this study. The total
number of subjects recruited in Sango-ota, Abeokuta, Ijebu-ode and Sagamu were 1120, 1116, 995
and 835, respectively. The mean age was 19 years (>1-70) with 93% less than 25 years.
Ethical consideration: Scientific and ethical clearance was obtained from the Nigerian Institute
of Medical Research-Institutional Review Board (NIMR-IRB) and Covenant University Ethics
Committee for this study. The Ogun State Ministry of Health (Hospitals Management Board) was
also informed and clearance obtained for this study. Written informed consent was obtained from
patients prior to recruitment into this study. Consent for the children was provided by the
parents/guardians while, some of the participants provided the assents by nodding.
Sample collection: Blood samples were collected for malaria screening from both finger prick and
venepuncture. This was to check the presence  of  healthy asexual parasites in the peripheral smear
of patients. Safety procedures were adopted in the collection of finger-prick blood samples by
swabbing the area to be sampled with 70% alcohol and allowed to dry before collection. The
bleeding was done in the hospitals by clinicians and medical laboratory scientists. About 2-5 mL
of blood was then drawn (venepuncture) with a sterile disposable syringe and transferred to a
heparinised centrifuge tube. The blood samples were transported to the laboratory at 4°C.
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Thick and thin film stained with Giemsa was prepared for the microscopic examination of the
malaria parasite. The thin films were fixed with methanol and all films were stained with 3%
Giemsa stain of pH 7.0 for 30 min as recommended by WHO (2000). Blood films were examined
microscopically using 100X (oil immersion) objectives as described by Cheesbrough (2000). The
thick films were used to determine the parasite densities while thin films were used to identify the
parasite species and infective stages. Parasite density per microliter of blood (parasitemia) was
estimated from the thick film, taking the number of leucocytes per microliter of blood as 8,000 and
was expressed as follows:
Parasite countParasite density (µL) = ×8000
No. of white blood cells counted
Questionnaire administration: Structured questionnaires indicating the locality, age and sex
of the respondents were administered to patients, parents of infants and older children. The
questionnaire was designed to identify the locality, age and sex of the respondents. In addition, the
patients’ attitude to use of antimalarial drugs and insecticide treated mosquito nets or other means
of controlling man-mosquito contact as practiced in the locality and malaria management practices
by the study population were also identified. A cross sectional study was conducted in the four
zones of Ogun State, Southwestern Nigeria. Data from all the questionnaires was coded, entered
and analyzed using Epi Info 6.04 and SPSS software.
RESULTS
A total of 4066 subjects comprising of 1839 males and 2227 females presenting with malaria
in four different senatorial districts of Ogun state were recruited into the study. The total number
of subjects recruited in Sango-ota, Abekuta, Ijebu-ode and Sagamu were 1120, 1116, 995 and 835,
respectively. The mean age was 19 years (>1-70) with 93% less than 25 years.
The overall prevalence of falciparum malaria as determined by microscopy in the study area
was 62.7%. The highest incidence was observed in Sango (75.7%) while, the lowest (48.4%) was
observed in Abeokuta. Table 1 shows the incidence of P. falciparum infection in Ogun State,
Nigeria according to age and sex while, Table 2 shows the zone wise incidence of malaria in the
study site. Age group 1-5 years had the highest incidence of infection (70.8) followed by age group
<1 year (63.9%) while, age group 6-15 years had the lowest incidence (52.8). The difference
according to age was statistically significant (p<0.0001). The  highest  falciparum  malaria  mean
Table 1: Prevalence of Plasmodium falciparum infection in Ogun State
No. of samples No. of positive cases Mean
----------------------------------------------------- ----------------------------------------------------- parasitemia
Age (years) Male Female Total Male (%) Female (%) Total (%) (p µLG1) p-value
<1 52 56 108 33 (47.8) 36 (52.2) 69 (63.9) 900.0 <0.0001 (χ2 = 46.863)
1-5 300 324 624 193 (43.7) 249 (56.3) 442 (70.8) 1080.0
6-15 330 412 742 195 (47.4) 197 (50.3) 392 (52.8) 890.0
16-25 901 965 1866 639 (60.8) 500 (44.0) 1139 (61.0) 850.0
26-40 208 221 429 110 (41.5) 155 (58.5) 265 (61.8) 990.0
>40 100 305 405 60 (24.7) 183 (75.3) 243 (60.0) 800.0
Total (%) 1839 (45.2) 2227 (54.8) 4066 (100) 1230 (48.2) 1320 (51.8) 2550 (62.7) 918.3
p-value <0.0001 (χ2 = 24.632)
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Table 2: Zone wise prevalence of malaria in Ogun State
No. of samples collected No. of positive samples
---------------------------------------------------------- ---------------------------------------------------------
Zone Male Female Total Male Female Total Mean parasitemia
Ijebu Ode (Ijebu) 455 540 995 315 348 663 (66.6) 920.0
Sango Ota (Yewa) 536 584 1120 412 436 848 (75.7) 914.0
Abeokuta (Egba) 502 614 1116 251 289 540 (48.4) 860.0
Sagamu (Remo) 346 489 835 252 247 499 (59.8) 980.0
Total (%) 1839 (45.2) 2227 (54.8) 4066 (100) 1230 (48.2) 1320 (51.8) 2550 (61.1) 918.3
Table 3: Knowledge on control of malaria among respondents
Variables N = 946 %
Episode of malaria infection
Once in a month 312.0 33.0
Once in three months 304.0 32.1
Twice in a year 144.0 15.2
Once in a year 141.0 14.9
Others 45.0 4.8
Reasons for stopping drug usage
When I feel okay/cured 340.0 35.9
Price of drugs 236.0 24.9
When I complete dosage 249.0 26.3
Anytime I like 121.0 12.8
Table 4: Knowledge on prevention of malaria among respondents
Variables N = 946 %
Antimalarial used as prophylaxis
Quinolines 385 40.7
Sulphonamides 316 33.5
Artesunate 74 7.9
Artemisinin combination therapies 30 3.2
Local herbs 142 15.1
Others 2 0.3
parasitemia of 1080 p µLG1 was recorded among the age group 1-5 years while age group >40 years
recorded the lowest mean parasitemia of 800 p µLG1. Females had a higher incidence of malaria
infection of 51.8% compared to males 48.2% in this study. The difference in the incidence of
infection by sex was significant (p<0.0001).
A  total  of  946  questionnaires  were  administered  to  assess  the  malaria  related  knowledge
on  issues  regarding  the  use  of  antimalarial  drugs  and  malaria  management  practices.  Most
of  the  respondents  were  students  (52.2%).  Other  occupations  of  the  respondents  are  shown
in Fig. 2. The responses of the participants are summarized in Table 3 and 4. About 32.1% of
participants  have  malaria  attack  at  least  once  in  3  months  while  only  26.3%  normally
complete their antimalarial drugs. The malaria management practices showed that 24.6% attend
hospitals, 12.0% use local healers while 25.0% buy antimalarial drugs without prescription by a
physician.  It  was  also  found  that  some  use  more  than  one  method  in  their  management
of malaria. Those who combined antimalarial drugs with traditional medicine from local healers
were found to be 17.4%, while 1.2% reported doing nothing about malaria. Figure 3 also shows the
methods  used  in  preventing  mosquito  bites  by  respondents.  Only  18%  of  the  sample
population used insecticide treated mosquito nets. Majority of the people (42.3%) used only window
and door nets, 24% of the population used insecticides while, 13% do not prevent mosquito bite at
all.
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Fig. 2: Percentage of respondents in different occupational divisions (N-946)
Fig. 3: Mosquito-bite preventive methods employed by respondents (N = 946)
DISCUSSION
Prevalence of Plasmodium falciparum which causes the most serious type of malaria especially
in sub Saharan Africa was studied in this research study among the people of Ogun State, Nigeria.
Malaria is the most prevalent tropical disease in the world today and in Sub-Saharan Africa, it is
ranked among the most frequent causes of morbidity and mortality especially among children and
is often the leading identifiable cause (Greenwood et al., 2005; Olasehinde et al., 2014). Four
thousand and sixty six subjects were included in the study on the prevalence of P. falciparum
infection in Ogun state, Southwestern Nigeria. Two thousand five hundred and fifty (62.7%) were
positive for falciparum malaria with an average parasitaemia of 918 (Table 1).
This result is in agreement with earlier observations that Nigeria is known for high prevalence
of malaria and it is a leading cause of morbidity and mortality in the country (Sowunmi et al., 2004;
Ademowo et al., 2007; Olasehinde et al., 2010). The high prevalence rate of falciparum malaria in
the selected study site is similar to the results of earlier studies in other parts of the country and
other neighboring countries. Adefioye et al. (2007) and Marielle et al. (2003) recorded a prevalence
rate of 72 and 70% among pregnant women in Oyo state, Nigeria and Gabon, respectively. A
prevalence rate of 76% was also reported by Aribodor et al. (2003) in Anambra State, South East
Nigeria. Moreover, Olasehinde et al. (2010) reported a prevalence rate of 80.5% among children
under 12 years in a cross sectional study in Southwestern Nigeria. The result of this study differs
from that of  Uko et al. (1998), who recorded a low prevalence rate of (6.8%). This may be due to the
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fact  that  the  study  was  carried  out  during  dry  season  alone  when  infection  rate  was  low.
Chanda et al. (2009) reported a very low incidence of 0.7% among children less than 5 years
attending a local health facility in Zambia.
In this study, 63.9% of children below one year and 70.8% of the children 1-5 years were positive
for falciparum malaria and highest parasitaemia was also observed in this age group. This was
followed by age range 16-25 years with a prevalence rate of 52.8%. In highly endemic malarious
area, where semi-immuned adults usually have substantially acquired resistance to local strains
of plasmodia, the prevalence of clinical malaria is higher and its severity greater in pregnant
women, children and young adults (WHO., 2003). The high prevalence rate in the study area could
result to cerebral malaria in children, maternal anaemia and low birth weight and death as
reported in earlier studies (Mockenhaupt et al., 2000; WHO., 2003; Olasehinde, 2010). This is
probably because they are more exposed to malaria parasite due to bad environmental conditions
and their life styles.
In considering possible strategies for the reduction of the burden of antimalarial drug
resistance, it is useful to differentiate between the current burden of drug resistance and the
potential burden in the future resulting from the continued emergence and spread of drug
resistance. The factors that are likely to contribute to the development of antimalarial resistance
were studied. Questionnaires were administered to respondents resident in the study sites who
were either malaria patients or parents/guardians of malaria infected children. The age of
respondents ranged between 14 and 75 years. A total of 946 questionnaires were administered to
assess the malaria related knowledge on issues regarding the use of antimalarial drugs and
malaria   management   practices.   The   responses   of   the   participants   are   summarized   in
Table 3 and 4. About 33% of respondents do have malaria at least once in a month while 32.1% of
participants have malaria attack at least once in 3 months and only 26.3% normally complete their
antimalarial drugs. The malaria management practices (Table 3) showed that 24.6% attend
hospitals, 12.0% use local healers while, 25.0% buy antimalarial drugs without prescription by a
physician. It was also found that some use more than one method in their management of malaria.
Those who combined antimalarial drugs with traditional medicine from local healers were found
to be 17.4%, while 1.2% reported doing nothing about malaria. Figure 3 also shows the methods
used in preventing mosquito bites by respondents. Only 18% of the sample population used
insecticide treated mosquito nets. Majority of the people (42.3%) used only window and door nets,
while, 13% do not prevent mosquito bite at all.
It was also found in this study that the rate of exposure to antimalarial drugs including the
artemisinins is very high. About 40.7% of the sample population used quinolines as prophylaxis
while,  more  than  33%  used  sulphonamides  and  about  3.2%  used  artemisinins  as  prophylaxis
(Table 4). As long as drugs are used, the chance of resistance developing to those drugs is present
(Plowe, 2003). It has been observed that the development of resistance to antimalarial drugs in
South-East Asia has been far quicker than the estimated 12-17 years it takes to develop and
market a new antimalarial compound (Ridley, 1997).
Affordability is an essential consideration for any strategy to control drug-resistant malaria,
especially in Africa (Goodman et al., 1999; Olasehinde et al., 2014). In the current study, about 25%
of the sample population stopped the use of drugs because of price or when they finish the one they
could afford. The future, especially in Africa, will also be defined by how well the central tenets of
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malaria control can be reconciled with the central tenets of control of drug resistance. One of the
cornerstones of the current approach to malaria control is the provision of prompt, effective malaria
treatment. In many parts of Africa, easy access to public sector health care is limited and when it
is accessible, health care staff are often inadequately trained, insufficiently supplied and supported,
ineffectively supervised and poorly motivated (Goodman et al., 2000).
Central to achieving a reduction in both current and future burdens is an improvement in drug
usage by patients and providers so that good quality drugs are available and taken at the correct
dose and for a sufficient length of time to affect a radical cure and reduce the likelihood that
partially resistant parasites will survive (Olasehinde, 2011). Improving drug use is most effective
where the parasite is still sensitive to the drug. Where resistance has rendered the drug ineffective,
the current burden of resistance can only be reduced by replacing the failing drug regimen with one
that is effective. The difficulty lies in deciding which drug regimen to switch to, since the choice of
drug or drug combination will determine the subsequent development of drug resistance. Reducing
the future burden of resistance requires that effective antimalarial drugs continue to be available
in the future and requires the continuous search for and development of potential new antimalarial
drugs.
To prevent resistance to antimalarial drugs, a high degree of vigilance is required to contain
the predisposing factors to resistance especially in the endemic regions, the level of antimalarial
drug sensitivity of P. falciparum should be closely monitored while compliance to antimalarial drug
use should be encouraged.
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